|
1
|
Wallace MC, Preen D, Jeffrey GP and Adams
LA: The evolving epidemiology of hepatocellular carcinoma: A global
perspective. Expert Rev Gastroenterol Hepatol. 9:765–779. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wahid B, Ali A, Rafique S and Idrees M:
New insights into the epigenetics of hepatocellular carcinoma.
Biomed Res Int. 2017:16095752017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Y, Ma L, Sheng S, Yuan Z, Zheng J and
Li W: Combination therapy of TACE and CT-guided partial hepatic
segment ablation for liver cancer. Minim Invasive Ther Allied
Technol. 1–10. 2018.(Epub ahead of print). View Article : Google Scholar
|
|
4
|
Feng GX, Li J, Yang Z, Zhang SQ, Liu YX,
Zhang WY, Ye LH and Zhang XD: Hepatitis B virus X protein promotes
the development of liver fibrosis and hepatoma through
downregulation miR-30e targeting P4HA2 mRNA. Oncogene.
36:6895–6905. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Castelli G, Pelosi E and Testa U: Liver
cancer: Molecular characterization, clonal evolution and cancer
stem cells. Cancers (Basel). 9(pii): E1272017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li XY, Wen JY, Jia CC, Wang TT, Li X, Dong
M, Lin QU, Chen ZH, Ma XK, Wei LI, et al: MicroRNA-34a-5p enhances
sensitivity to chemotherapy by targeting AXL in hepatocellular
carcinoma MHCC-97L cells. Oncol Lett. 10:2691–2698. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Raposo G and Stoorvogel W: Extracellular
vesicles: Exosomes, microvesicles, and friends. J Cell Biol.
200:373–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pugholm LH, Revenfeld AL, Søndergaard EK
and Jørgensen MM: Antibody-based assays for phenotyping of
extracellular vesicles. Biomed Res Int. 2015:5248172015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Geis-Asteggiante L, Belew AT, Clements VK,
Edwards NJ, Ostrand-Rosenberg S, El-Sayed NM and Fenselau C:
Differential content of proteins, mRNAs, and miRNAs suggests that
MDSC and their exosomes may mediate distinct immune suppressive
functions. J Proteome Res. 17:486–498. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oushy S, Hellwinkel JE, Wang M, Nguyen GJ,
Gunaydin D, Harland TA, Anchordoquy TJ and Graner MW: Glioblastoma
multiforme-derived extracellular vesicles drive normal astrocytes
towards a tumour-enhancing phenotype. Philos Trans R Soc Lond B
Biol Sci. 373(pii): 201604772018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kawakubo-Yasukochi T, Morioka M, Hazekawa
M, Yasukochi A, Nishinakagawa T, Ono K, Kawano S, Nakamura S and
Nakashima M: miR-200c-3p spreads invasive capacity in human oral
squamous cell carcinoma microenvironment. Mol Carcinog. 57:295–302.
2018. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Min QH, Wang XZ, Zhang J, Chen QG, Li SQ,
Liu XQ, Li J, Liu J, Yang WM, Jiang YH, et al: Exosomes derived
from imatinib-resistant chronic myeloid leukemia cells mediate a
horizontal transfer of drug-resistant trait by delivering miR-365.
Exp Cell Res. 362:386–393. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Samuel P, Mulcahy LA, Furlong F, McCarthy
HO, Brooks SA, Fabbri M, Pink RC and Carter DRF: Cisplatin induces
the release of extracellular vesicles from ovarian cancer cells
that can induce invasiveness and drug resistance in bystander
cells. Philos Trans R Soc Lond B Biol Sci. 373(pii): 201700652018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qu Z, Wu J, Wu J, Luo D, Jiang C and Ding
Y: Exosomes derived from HCC cells induce sorafenib resistance in
hepatocellular carcinoma both in vivo and in vitro. J Exp Clin
Cancer Res. 35:1592016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Catarino S, Pereira P and Girão H:
Molecular control of chaperone-mediated autophagy. Essays Biochem.
61:663–674. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han Q, Deng Y, Chen S, Chen R, Yng M,
Zhang Z, Sun X, Wang W, He Y, Wang F, et al: Downregulation of
ATG5-dependent macroautophagy by chaperone-mediated autophagy
promotes breast cancer cell metastasis. Sci Rep. 7:47592017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dewaele M, Martinet W, Rubio N, Verfaillie
T, de Witte PA, Piette J and Agostinis P: Autophagy pathways
activated in response to PDT contribute to cell resistance against
ROS damage. J Cell Mol Med. 15:1402–1414. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saha T: LAMP2A overexpression in breast
tumors promotes cancer cell survival via chaperone-mediated
autophagy. Autophagy. 8:1643–1656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Oehme I, Linke JP, Böck BC, Milde T,
Lodrini M, Hartenstein B, Wiegand I, Eckert C, Roth W, Kool M, et
al: Histone deacetylase 10 promotes autophagy-mediated cell
survival. Proc Natl Acad Sci USA. 110:E2592–E2601. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qin S; Primary Liver Cancer Diagnosis and
Treatment Expert Panel of the Chinese Ministry of Health, .
Guidelines on the diagnosis and treatment of primary liver cancer
(2011 edition). Chin Clin Oncol. 1:102012.PubMed/NCBI
|
|
21
|
Lee TY, Lin CC, Chen CY, Wang TE, Lo GH,
Chang CS and Chao Y; Combination of transcatheter arterial
chemoembolization and interrupted dosing sorafenib improves patient
survival in early-intermediate stage hepatocellular carcinoma, . A
post hoc analysis of the START trial. Medicine (Baltimore).
96:e76552017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamakado K, Miyayama S, Hirota S, Mizunuma
K, Nakamura K, Inaba Y, Maeda H, Matsuo K, Nishida N, Aramaki T, et
al: Subgrouping of intermediate-stage (BCLC stage B) hepatocellular
carcinoma based on tumor number and size and Child-Pugh grade
correlated with prognosis after transarterial chemoembolization.
Jpn J Radiol. 32:260–265. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
European Association For The Study Of The
Liver1; European Organisation For Research And Treatment Of Cancer.
EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
|
25
|
Paran N, Geiger B and Shaul Y: HBV
infection of cell culture: Evidence for multivalent and cooperative
attachment. EMBO J. 20:4443–4453. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo D, Cheng SC, Xie H and Xie Y: Effects
of Bcl-2 and Bcl-XL protein levels on chemoresistance of
hepatoblastoma HepG2 cell line. Biochem Cell Biol. 78:119–126.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hsiao CC, Chen PH, Cheng CI, Tsai MS,
Chang CY, Lu SC, Hsieh MC, Lin YC, Lee PH and Kao YH: Toll-like
receptor-4 is a target for suppression of proliferation and
chemoresistance in HepG2 hepatoblastoma cells. Cancer Lett.
368:144–152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vander Borght S, van Pelt J, van
Malenstein H, Cassiman D, Renard M, Verslype C, Libbrecht L and
Roskams TA: Up-regulation of breast cancer resistance protein
expression in hepatoblastoma following chemotherapy: A study in
patients and in vitro. Hepatol Res. 38:1112–1121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rapti I and Hadziyannis S: Risk for
hepatocellular carcinoma in the course of chronic hepatitis B virus
infection and the protective effect of therapy with nucleos(t)ide
analogues. World J Hepatol. 7:1064–1073. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shirvani-Dastgerdi E, Winer BY,
Celià-Terrassa T, Kang Y, Tabernero D, Yagmur E, Rodríguez-Frías F,
Gregori J, Luedde T, Trautwein C, et al: Selection of the highly
replicative and partially multidrug resistant rtS78T HBV polymerase
mutation during TDF-ETV combination therapy. J Hepatol. 67:246–254.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lamontagne J, Steel LF and Bouchard MJ:
Hepatitis B virus and microRNAs: Complex interactions affecting
hepatitis B virus replication and hepatitis B virus-associated
diseasses. World J Gastroenterol. 21:7375–7399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Samal J, Kandpal M and Vivekanandan P:
HBeAg-induced miR-106b promotes cell growth by targeting the
retinoblastoma gene. Sci Rep. 7:143712017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fan H, Zhang Q, Zhao X, Lv P, Liu M and
Tang H: Transcriptomic profiling of long non-coding RNAs in
hepatitis B virus-related hepatocellular carcinoma. Oncotarget.
8:65421–65434. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Moyo B, Nicholson SA and Arbuthnot PB: The
role of long non-coding RNAs in hepatitis B virus-related
hepatocellular carcinoma. Virus Res. 212:103–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bayraktar R, Van Roosbroeck K and Calin
GA: Cell to cell communication: microRNAs as hormones. Mol Oncol.
11:1673–1686. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Challagundla KB, Wise PM, Neviani P, Chava
H, Murtadha M, Xu T, Kennedy R, Ivan C, Zhang X, Vannini I, et al:
Exosome-mediated transfer of microRNAs within the tumor
microenvironment and neuroblastoma resistance to chemotherapy. J
Natl Cancer Inst. 107(pii): djv1352015.PubMed/NCBI
|
|
37
|
Santos JC, Lima NDS, Sarian LO, Matheu A,
Ribeiro ML and Derchain SFM: Exosome-mediated breast cancer
chemoresistance via miR-155 transfer. Sci Rep. 8:8292018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y,
Yoon T, Azzam DJ, Twyman-Saint Victor C, Wiemann BZ, Ishwaran H, et
al: Exosome transfer from stromal to breast cancer cells regulates
therapy resistance pathways. Cell. 159:499–513. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li L, Fang R, Liu B, Shi H, Wang Y, Zhang
W, Zhang X and Ye L: Deacetylation of tumor-suppressor MST1 in
Hippo pathway induces its degradation through HBXIP-elevated HDAC6
in promotion of breast cancer growth. Oncogene. 35:4048–4057. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J5, Rahbari
N, et al: Glypican-1 identifies cancer exosomes and detects early
pancreatic cancer. Nature. 523:177–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu JH, Guo JP, Shi J, Wang H, Li LL, Guo
B, Liu DX, Cao Q and Yuan ZY: CMA down-regulates p53 expression
through degradation of HMGB1 protein to inhibit
irradiation-triggered apoptosis in hepatocellular carcinoma. World
J Gastroenterol. 23:2308–2317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li XJ, Ren ZJ, Tang JH and Yu Q: Exosomal
microRNA MiR-1246 promotes cell proliferation, invasion and drug
resistance by targeting CCNG2 in breast cancer. Cell Physiol
Biochem. 44:1741–1748. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao
Y, Li Y, Zeng T, Hu J, Zhang L, et al: HBx-mediated miR-21
upregulation represses tumor-suppressor function of PDCD4 in
hepatocellular carcinoma. Oncogene. 32:3296–3305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kouwaki M, Fukushima Y, Daito T, Sanada T,
Yamamoto N, Mifsud EJ, Leong CR, Tsukiyama-Kohara K, Kohara M,
Matsumoto M, et al: Extracellular vesicles including exosomes
regulate innate immune responses to hepatitis B virus infection.
Front Immunol. 7:3352016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Damania P, Sen B, Dar SB, Kumar S, Kumari
A, Gupta E, Sarin SK and Venugopal SK: Hepatitis B virus induces
cell proliferation via HBx-induced microRNA-21 in hepatocellular
carcinoma by targeting programmed cell death protein4 (PDCD4) and
phosphatase and tensin homologue (PTEN). PLoS One. 9:e917452014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Campos-Parra AD, Mitznahuat1 GC,
Pedroza-Torres A, Romo RV, Reyes FIP, López-Urrutia E and
Pérez-Plasencia C: Micro-RNAs as potential predictors of response
to breast cancer systemic therapy: Future clinical implications.
Int J Mol Sci. 18(pii): E11822017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Malla B, Aebersold DM and Dal Pra A:
Protocol for serum exosomal miRNAs analysis in prostate cancer
patients treated with radiotherapy. J Transl Med. 16:2232018.
View Article : Google Scholar : PubMed/NCBI
|
